The store will not work correctly when cookies are disabled.
2-(5-tert-Butylisoxazol-3-yl)-N'-(2-chlorophenyl)-2-oxoacetohydrazonoyl Cyanide
ID: ALA3594317
PubChem CID: 71711930
Max Phase: Preclinical
Molecular Formula: C16H15ClN4O2
Molecular Weight: 330.78
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1cc(C(=O)/C(C#N)=N/Nc2ccccc2Cl)no1
Standard InChI: InChI=1S/C16H15ClN4O2/c1-16(2,3)14-8-12(21-23-14)15(22)13(9-18)20-19-11-7-5-4-6-10(11)17/h4-8,19H,1-3H3/b20-13+
Standard InChI Key: MLEIAPIKRLXYAB-DEDYPNTBSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 -3.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3039 -3.7494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3070 -5.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6078 -5.9988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0086 -6.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0296 -6.6047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6109 -7.4996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6460 -5.3970 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8244 -8.3594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3609 -9.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8609 -9.7860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3974 -8.3594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2416 -10.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4351 -10.8734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7532 -12.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9465 -11.9692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
9 11 1 0
11 12 3 0
10 13 1 0
10 14 2 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 13 2 0
16 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
5 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.78 | Molecular Weight (Monoisotopic): 330.0884 | AlogP: 3.80 | #Rotatable Bonds: 4 |
Polar Surface Area: 91.28 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.69 | CX Basic pKa: ┄ | CX LogP: 4.94 | CX LogD: 3.20 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.52 | Np Likeness Score: -1.66 |
References
1. Ye N, Zhu Y, Chen H, Liu Z, Mei FC, Wild C, Chen H, Cheng X, Zhou J.. (2015) Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists., 58 (15): [PMID:26151319] [10.1021/acs.jmedchem.5b00635] |